Search
Agios Pharmaceuticals Inc
AGIOAdd to Watchlist
30.020USD
-2.730-8.34%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.79BMarket Cap
LossP/E TTM
Financial Health
Currency: USD Updated: 2026-07-31 The current financial score of Agios Pharmaceuticals Inc is 6.96, ranking 170 out of 385 in the Biotechnology & Medical Research industry. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 44.74M, representing a year-over-year increase of 259.25%, while its net profit experienced a year-over-year increase of 10.10%.
Financials
7.20
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
8.14
Total revenue
Operating profit
Total assets
SG&A
Relevant data have not been disclosed by the company yet.
Operational Efficiency
2.99
Cash flow from operating activities
Income after tax
Relevant data have not been disclosed by the company yet.
Growth Potential
9.08
Cash flow from operating activities
Total revenue
Relevant data have not been disclosed by the company yet.
Shareholder Returns
7.40
Free cash flow
Relevant data have not been disclosed by the company yet.